Alphinity Investment Management Pty Ltd Decreases Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Alphinity Investment Management Pty Ltd cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.9% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,095,223 shares of the medical equipment provider’s stock after selling 68,645 shares during the period. Intuitive Surgical comprises about 3.1% of Alphinity Investment Management Pty Ltd’s holdings, making the stock its 19th largest position. Alphinity Investment Management Pty Ltd’s holdings in Intuitive Surgical were worth $571,663,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Versor Investments LP purchased a new position in Intuitive Surgical in the 4th quarter valued at about $248,000. Proficio Capital Partners LLC lifted its holdings in Intuitive Surgical by 89,098.8% in the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after purchasing an additional 948,902 shares in the last quarter. Kovack Advisors Inc. lifted its holdings in Intuitive Surgical by 21.5% in the 4th quarter. Kovack Advisors Inc. now owns 1,686 shares of the medical equipment provider’s stock valued at $880,000 after purchasing an additional 298 shares in the last quarter. Mn Services Vermogensbeheer B.V. lifted its holdings in Intuitive Surgical by 2.2% in the 4th quarter. Mn Services Vermogensbeheer B.V. now owns 139,100 shares of the medical equipment provider’s stock valued at $72,605,000 after purchasing an additional 3,000 shares in the last quarter. Finally, New York Life Investment Management LLC lifted its holdings in Intuitive Surgical by 12.8% in the 4th quarter. New York Life Investment Management LLC now owns 53,339 shares of the medical equipment provider’s stock valued at $27,841,000 after purchasing an additional 6,069 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $580.93 on Thursday. The firm has a fifty day moving average of $568.10 and a two-hundred day moving average of $527.65. The firm has a market cap of $206.92 billion, a P/E ratio of 90.63, a P/E/G ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Insider Activity

In other news, EVP Myriam Curet sold 408 shares of the company’s stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the sale, the executive vice president now owns 353 shares in the company, valued at approximately $208,181.75. This represents a 53.61 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 6,240 shares of company stock worth $3,529,040. 0.80% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the stock. Truist Financial upped their target price on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a report on Friday, January 24th. JPMorgan Chase & Co. increased their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Stifel Nicolaus increased their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. Citigroup increased their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Finally, Barclays increased their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.